News

Unplanned hospitalizations common among elders with gastrointestinal cancers


 

FROM THE JOURNAL OF CLINICAL ONCOLOGY

References

Unplanned hospitalizations are common among older adults with gastrointestinal cancers, especially in the first few months after surgery or chemotherapy.

About 60% experienced at least one unplanned admission, most often for fluid and electrolyte disorders, intestinal obstruction, or pneumonia, Dr. Joanna-Grace M. Manzano and her associates reported (J. Clin. Oncol. 2014 Oct. 6 [doi:10.1200/JCO.2014.55.3131]).

A number of demographic and clinical characteristics increased the risk of such admissions, including black race, low socioeconomic status, dual Medicare/Medicaid eligibility, multiple comorbidities, and advanced disease, said Dr. Manzano of the University of Texas MD Anderson Cancer Center, Houston, and her coauthors. Patients with pancreatic, gastric, and esophageal cancers were especially at risk, they noted.

The team reviewed the medical claims of 30,199 patients older than 66 years who had a diagnosis of gastrointestinal cancer. The mean observation time was 15 months. Among these, there were 60,837 claims; more than half of those were for unplanned hospitalizations. The mean time to first admission was about 2 months after oncologic treatment.

Of those who had such a hospitalization, 19% had undergone chemotherapy, radiotherapy, or a surgical procedure in the prior 30 days. In addition, 9% had visited an emergency department.

Understanding these risk factors could help clinicians keep a preemptive eye out for problems. “Knowing who is at risk for an unplanned hospitalization also opens up opportunities for

anticipatory guidance and patient education during the active phase of treatment,” the investigators wrote.

The authors had no financial disclosures.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Recommended Reading

Pediatric IBD rose by more than 40% in 15 years
MDedge Internal Medicine
Drug combinations found to increase upper gastrointestinal bleeding risk
MDedge Internal Medicine
MicroRNA test improved preop pancreatic cancer diagnosis
MDedge Internal Medicine
Model could cut CT scans of patients with Crohn’s disease by 43%
MDedge Internal Medicine
Transanal extraction found effective in rectal cancer surgery
MDedge Internal Medicine
TNF blocker adalimumab approved for pediatric Crohn’s disease
MDedge Internal Medicine
New drug boosts survival in metastatic CRC
MDedge Internal Medicine
Duodenoscopes transmitted resistant E. coli to 39 patients
MDedge Internal Medicine
VIDEO: New drug shows efficacy in metastatic CRC
MDedge Internal Medicine
Efficacy, not tolerability, of bowel prep is primary
MDedge Internal Medicine